New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
ImmunoGen, Inc.
IMGN
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

9B

Biotechnology

Next Earning date - 31 Oct 2024

9B

Biotechnology

Next Earning date - 31 Oct 2024

31.23USD
Shape0.01 ( 0.02%)
Market Open
favorite-chart

Relative Strenght

99
favorite-chart

Volume Buzz

133%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

0%

Quote Panel

Shape
Updated October 29, 2024
1W % 1M % 3M % 1Y 122.44 %

Key Metrics

Shape
  • Market Cap

    8.73B


  • Shares Outstanding

    279.35M


  • Share in Float

    247.85M


  • Dividende

    0


  • Earning Date

    31 Oct 2024


  • Price Target

    31.235


  • Average Volume

    8.29M


  • Beta

    1.171


  • Range

    3.61-31.25


  • Industry

    Biotechnology


  • Website

    https://www.immunogen.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

30.34x

P/S Ratio

16.00x

P/B Ratio

0.1

Debt/Equity

-25.4%

Net Margin

$-0.3

EPS

How IMGN compares to sector?

P/E Ratio

Relative Strength

Shape

IMGN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$538M

Shape9%

2025-Revenue

$0.35

Shape597%

2025-EPS

$425M

Shape-138%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

William Blair

upgrade

Previous: Not converted

2024-01-29

Now: Outperform

Piper Sandler

downgrade

Previous: Overweight

2023-12-04

Now: Neutral

Credit Suisse

downgrade

Previous: Not converted

2023-09-13

Now: Neutral

Piper Sandler

upgrade

Previous: Not converted

2023-05-03

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

N/A

-0.17
vs 0.16

Q1.22

arrow
arrow

N/A

-0.10
vs -0.17

Q2.22

arrow
arrow

N/A

-0.24
vs -0.15

Q3.22

arrow
arrow

N/A

-0.31
vs -0.18

Q4.22

arrow
arrow

N/A

-0.23
vs -0.17

Q1.23

arrow
arrow

N/A

-0.16
vs -0.10

Q2.23

arrow
arrow

N/A

-0.02
vs -0.24

Q3.23

arrow
arrow

+132%

0.1
vs -0.31

Q4.23

arrow
arrow

N/A

-0.16
vs -0.23

Q1.24

arrow
arrow

+156%

0.09
vs -0.16

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

-67%

28M  vs 85.8M

Q1.22

arrow
arrow

+142%

38.1M  vs 15.7M

Q2.22

arrow
arrow

-16%

14.2M  vs 16.9M

Q3.22

arrow
arrow

+67%

15.4M  vs 9.2M

Q4.22

arrow
arrow

+47%

41.2M  vs 28M

Q1.23

arrow
arrow

+31%

49.9M  vs 38.1M

Q2.23

arrow
arrow

+487%

83.2M  vs 14.2M

Q3.23

arrow
arrow

+638%

113.4M  vs 15.4M

Q4.23

arrow
arrow

+17%

48.4M  vs 41.2M

Q1.24

arrow
arrow

+115%

107M  vs 49.9M

Return on EquityShape

status-upQoQ

Q4.21

arrow
arrow

-11%

-0.11
vs -0.48

Q1.22

arrow
arrow

-8%

-0.08
vs -0.11

Q2.22

arrow
arrow

-25%

-0.25
vs -0.08

Q3.22

arrow
arrow

-44%

-0.44
vs -0.25

Q4.22

arrow
arrow

-38%

-0.38
vs -0.44

Q1.23

arrow
arrow

-33%

-0.33
vs -0.38

Q2.23

arrow
arrow

-1%

-0.01
vs -0.33

Q3.23

arrow
arrow

+5%

0.05
vs -0.01

Institutionnal OwnershipShape

status-upQoQ

Q2.22

arrow
arrow

213

213
vs 223

-4%

Q3.22

arrow
arrow

217

217
vs 213

2%

Q4.22

arrow
arrow

210

210
vs 217

-3%

Q1.23

arrow
arrow

202

202
vs 210

-4%

Q2.23

arrow
arrow

292

292
vs 202

45%

Q3.23

arrow
arrow

295

295
vs 292

1%

Q4.23

arrow
arrow

368

368
vs 295

25%

Q1.24

arrow
arrow

4

4
vs 368

-99%

Earnings Growth

Latest News

IMGN

investopedia.com

12 hours ago